AMAG Pharmaceuticals Razão de venda descoberta
Qual é o Razão de venda descoberta de AMAG Pharmaceuticals?
O Razão de venda descoberta de AMAG Pharmaceuticals, Inc. é 1.83
Qual é a definição de Razão de venda descoberta?
Razão da venda descoberta é o número de acções vendidas a descoberto dividido pelo volume médio diário.
Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.
The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.
Razão de venda descoberta de empresas na Setor Health Care em NASDAQ em comparação com AMAG Pharmaceuticals
O que AMAG Pharmaceuticals faz?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Empresas com razão de venda descoberta semelhantes a AMAG Pharmaceuticals
- CDK Global Inc tem Razão de venda descoberta de 1.82
- Altria tem Razão de venda descoberta de 1.82
- Brasilagro Companhia Brasileira De Propriedade Agricola tem Razão de venda descoberta de 1.82
- BlackRock TCP Capital Corp tem Razão de venda descoberta de 1.82
- TORM plc tem Razão de venda descoberta de 1.82
- H&R Real Estate Investment Trust tem Razão de venda descoberta de 1.82
- AMAG Pharmaceuticals tem Razão de venda descoberta de 1.83
- Elysee Development tem Razão de venda descoberta de 1.84
- In8 Bio tem Razão de venda descoberta de 1.84
- Graybug Vision tem Razão de venda descoberta de 1.84
- Western Asset Investment Grade Income Fund Inc tem Razão de venda descoberta de 1.84
- Fortinet Inc tem Razão de venda descoberta de 1.84
- National tem Razão de venda descoberta de 1.84